loading
Precedente Chiudi:
$33.58
Aprire:
$33.76
Volume 24 ore:
356.17K
Relative Volume:
0.46
Capitalizzazione di mercato:
$1.47B
Reddito:
$384.10M
Utile/perdita netta:
$-9.07M
Rapporto P/E:
-241.07
EPS:
-0.14
Flusso di cassa netto:
$11.10M
1 W Prestazione:
+1.11%
1M Prestazione:
+22.11%
6M Prestazione:
+68.58%
1 anno Prestazione:
+28.77%
Intervallo 1D:
Value
$33.53
$34.24
Intervallo di 1 settimana:
Value
$32.90
$34.55
Portata 52W:
Value
$17.82
$34.55

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name
Nome
Kiniksa Pharmaceuticals International Plc
Name
Telefono
(781) 431-9100
Name
Indirizzo
23 OLD BOND STREET, FLOOR 3, LONDON
Name
Dipendente
315
Name
Cinguettio
@kiniksa
Name
Prossima data di guadagno
2024-10-29
Name
Ultimi documenti SEC
Name
KNSA's Discussions on Twitter

Confronta KNSA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
KNSA
Kiniksa Pharmaceuticals International Plc
33.75 2.50B 384.10M -9.07M 11.10M -0.14
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.62 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.52 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.82 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.46 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.23 14.21B 2.99B 1.21B 1.13B 25.06

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato Citigroup Buy
2024-09-13 Iniziato Jefferies Buy
2024-05-03 Iniziato Wells Fargo Overweight
2020-06-29 Reiterato BofA Securities Buy
2020-04-01 Iniziato BofA/Merrill Buy
2019-03-11 Iniziato Barclays Overweight
2018-12-12 Reiterato Wedbush Outperform
2018-06-19 Iniziato JMP Securities Mkt Outperform
Mostra tutto

Kiniksa Pharmaceuticals International Plc Borsa (KNSA) Ultime notizie

pulisher
Aug 20, 2025

Wall Street Analysts Believe Kiniksa Pharmaceuticals International, plc (KNSA) Could Rally 26.69%: Here's is How to Trade - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 12-Month HighHere's What Happened - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Deutsche Bank AG Has $8.76 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Director Sells $1,600,786.80 in Stock - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Thomas Malley Sells 78,233 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock - MarketBeat

Aug 20, 2025
pulisher
Aug 19, 2025

Thomas Malley Sells 50,129 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat

Aug 19, 2025
pulisher
Aug 19, 2025

Is Kiniksa Pharmaceuticals Ltd. stock entering bullish territoryWeekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance

Aug 18, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 04:40:11 - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Connor Clark & Lunn Investment Management Ltd. Buys 92,797 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Aug 16, 2025
pulisher
Aug 14, 2025

Zacks.com featured highlights include Modine Manufacturing, Tutor Perini, Kiniksa Pharmaceuticals International and Euroseas - Barchart.com

Aug 14, 2025
pulisher
Aug 13, 2025

Insider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Insider Sells 29,325 Shares of Stock - MarketBeat

Aug 13, 2025
pulisher
Aug 12, 2025

Eben Tessari Sells 138,614 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat

Aug 12, 2025
pulisher
Aug 11, 2025

Michael R. Megna Sells 17,000 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Stock - MarketBeat

Aug 11, 2025
pulisher
Aug 10, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) CFO Sells $621,259.21 in Stock - MarketBeat

Aug 10, 2025
pulisher
Aug 09, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month HighShould You Buy? - MarketBeat

Aug 09, 2025
pulisher
Aug 08, 2025

BIT Capital GmbH Takes $264,000 Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Aug 08, 2025
pulisher
Aug 07, 2025

J.P. Morgan Maintains Buy Rating on Kiniksa Pharmaceuticals with $55 Price Target - AInvest

Aug 07, 2025
pulisher
Aug 05, 2025

Kiniksa Pharmaceuticals International, plc (KNSA) Is Up 21.46% in One Week: What You Should Know - Yahoo Finance

Aug 05, 2025
pulisher
Aug 05, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Upgraded at Wall Street Zen - Defense World

Aug 05, 2025
pulisher
Aug 04, 2025

Kiniksa Pharmaceuticals surges 11.01% on Arcalyst's market penetration - AInvest

Aug 04, 2025
pulisher
Aug 04, 2025

Victory Capital Management Inc. Makes New Investment in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Aug 04, 2025
pulisher
Aug 02, 2025

Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect? - MSN

Aug 02, 2025

Kiniksa Pharmaceuticals International Plc Azioni (KNSA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Kiniksa Pharmaceuticals International Plc Azioni (KNSA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Malley Thomas
Director
Aug 14 '25
Option Exercise
14.89
78,233
1,165,028
90,779
Malley Thomas
Director
Aug 13 '25
Option Exercise
10.07
50,129
504,936
62,675
Malley Thomas
Director
Aug 12 '25
Option Exercise
2.94
49,407
145,146
61,953
Malley Thomas
Director
Aug 14 '25
Sale
33.09
78,233
2,588,730
12,546
Malley Thomas
Director
Aug 13 '25
Sale
33.32
50,129
1,670,298
12,546
Malley Thomas
Director
Aug 12 '25
Sale
32.40
49,407
1,600,787
12,546
$29.75
price up icon 2.37%
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
Capitalizzazione:     |  Volume (24 ore):